Zionsville, INCIK 16168244 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
13 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Aclaris Therapeutics Inc | 14.25M | $42.89M | 38.0% | 0 | Held |
| 2 | Atea Pharmaceuticals Inc | 7.49M | $26.74M | 23.7% | +16.0K | Added |
| 3 | Oramed Pharmaceuticals Inc | 3.17M | $9.03M | 8.0% | 0 | Held |
| 4 | Instil Bio Inc |
| 645.6K |
| $7.10M |
| 6.3% |
| 0 |
| Held |
| 5 | Pmv Pharmaceuticals Inc | 5.29M | $6.62M | 5.9% | 0 | Held |
| 6 | Carmax Inc | 155.0K | $5.99M | 5.3% | +155.0K | New |
| 7 | Kezar Life Sciences Inc | 720.8K | $4.53M | 4.0% | 0 | Held |
| 8 | Target Corp | 37.5K | $3.67M | 3.2% | +27.5K | Added |
| 9 | Outset Med Inc | 543.2K | $2.02M | 1.8% | +543.2K | New |
| 10 | Pliant Therapeutics Inc | 1.55M | $1.89M | 1.7% | +1.55M | New |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio